Clinical Trials Updated in 2026

NCT06465511 | RECRUITING | NA

68 participants

Supportive Clinic for Patients Living With Advanced and Metastatic Cancers

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2025-05-21
Completion:: 2027-12-31

Conditions

Cancer
Physical Symptom Distress

Interventions

BEHAVIORAL

No Results Yet

NCT06462430 | RECRUITING

100 participants

PTEN Hamartoma Tumor Syndrome Pediatric Patient Registry

Study Type:: OBSERVATIONAL
Last Updated:: 2026-08-31
Start Date:: 2022-11-01
Completion:: 2026-12-01

Conditions

PTEN Hamartoma Tumor Syndrome
Macrocephaly Autism Syndrome

No Results Yet

NCT06461234 | RECRUITING

1360 participants

Pelvic Floor Rehabilitation of Female Pelvic Floor Dysfunction

Study Type:: OBSERVATIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-05-20
Completion:: 2026-11-30

Conditions

Pelvic Floor Disorders
Pelvic Organ Prolapse

Interventions

BEHAVIORAL
OTHER

No Results Yet

NCT06461156 | RECRUITING | PHASE1

230 participants

A Study of HS-10504 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-06-26
Completion:: 2026-12-31

Conditions

Locally Advanced or Metastatic NSCLC

Interventions

DRUG

No Results Yet

NCT06460298 | RECRUITING | PHASE1/PHASE2

51 participants

ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-08-20
Completion:: 2027-07-01

Conditions

Triple Negative Breast Cancer

Interventions

DRUG

No Results Yet

NCT06457490 | WITHHELD

[Trial of device that is not approved or cleared by the U.S. FDA]

Last Updated:: 2026-08-31

No Results Yet

NCT06455098 | ACTIVE_NOT_RECRUITING | NA

353 participants

A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-06-28
Completion:: 2027-07-31

Conditions

Atrial Fibrillation

Interventions

DEVICE

No Results Yet

NCT06450951 | COMPLETED | NA

1074 participants

A Personalized Biomonitoring and Report-back Intervention to Reduce Exposure to Endocrine Disrupting Chemicals

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-05-23
Completion:: 2026-02-28

Conditions

Environmental Exposure

Interventions

DIAGNOSTIC_TEST
BEHAVIORAL

No Results Yet

NCT06448754 | ACTIVE_NOT_RECRUITING | PHASE2

194 participants

Volrustomig Priming Regimens Exploratory Phase II Platform Study

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-08-27
Completion:: 2027-07-30

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG

No Results Yet

NCT06447168 | RECRUITING

424 participants

A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

Study Type:: OBSERVATIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-10-14
Completion:: 2032-07-15

Conditions

Primary Biliary Cholangitis

No Results Yet

NCT06439836 | RECRUITING | PHASE1

27 participants

Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2025-05-05
Completion:: 2027-06-01

Conditions

Metastatic Urothelial Carcinoma
Unresectable Urothelial Carcinoma

Interventions

PROCEDURE
BIOLOGICAL

No Results Yet

NCT06439602 | COMPLETED | PHASE3

818 participants

Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-06-26
Completion:: 2026-03-20

Conditions

Gout
Arthritis, Gouty
Hyperuricemia
Gout Chronic

Interventions

DRUG

No Results Yet

NCT06438588 | TERMINATED | NA

2 participants

Fasting Mimicking Diet for Reducing Immune Related Adverse Events for Cancer Patients on Immune Checkpoint Inhibitors, FMD-ICI Trial

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-11-11
Completion:: 2026-02-05

Conditions

Advanced Malignant Solid Neoplasm

Interventions

PROCEDURE
OTHER

No Results Yet

NCT06433752 | RECRUITING

2000 participants

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Study Type:: OBSERVATIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-07-22
Completion:: 2032-04-01

Conditions

Relapsing Multiple Sclerosis
Multiple Sclerosis

Interventions

OTHER

No Results Yet

NCT06422143 | RECRUITING | PHASE3

851 participants

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-06-10
Completion:: 2029-01-12

Conditions

Non-small Cell Lung Cancer
NSCLC

Interventions

BIOLOGICAL
DRUG

No Results Yet

NCT06415357 | COMPLETED | NA

164 participants

Zambia Healthy Choices Project for Emerging Adults Living With HIV

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-04-20
Completion:: 2026-06-30

Conditions

Pre-Exposure Prophylaxis

Interventions

BEHAVIORAL

No Results Yet

NCT06411574 | COMPLETED | NA

16 participants

Body Surface Gastric Mapping vs Gastric Emptying Scintigraphy on Clinical Management in Gastroparesis

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-05-03
Completion:: 2025-01-30

Conditions

Gastroparesis

Interventions

DEVICE

Results Available

NCT06406465 | RECRUITING | PHASE2

60 participants

A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2026-09-03
Completion:: 2027-07-30

Conditions

Carcinoma, Neuroendocrine
Tumor, Neuroendocrine
Tumors, Neuroendocrine
Neuroendocrine; Carcinoma
Small Cell; Receptors

Interventions

DRUG

No Results Yet

NCT06401746 | COMPLETED

9 participants

Body Surface Gastric Mapping in Patients on Semaglutide

Study Type:: OBSERVATIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-05-01
Completion:: 2025-03-13

Conditions

Semaglutide-Induced Gastric Motility
Gastroparesis

Interventions

DEVICE

Results Available

NCT06400303 | TERMINATED | PHASE1/PHASE2

3 participants

KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-08-06
Completion:: 2026-06-16

Conditions

Systemic Sclerosis
Systemic Sclerosis - Diffuse Cutaneous
Systemic Sclerosis - 2013 ACR/EULAR Classification Criteria

Interventions

BIOLOGICAL
DRUG

No Results Yet

NCT06398418 | RECRUITING | PHASE1

33 participants

R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2025-08-01
Completion:: 2027-04-30

Conditions

Solid Tumor, Adult
Solid Tumor
Melanoma
Basal Cell Cancer
Squamous Cell Cancer
Adenoma

Interventions

DRUG

No Results Yet

NCT06377293 | ACTIVE_NOT_RECRUITING | NA

50 participants

Effect of Dialysis-specific Therapeutic Diet on Biochemical Parameters in Dialysis Patients

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2025-05-01
Completion:: 2025-12-04

Conditions

End-Stage Kidney Disease

Interventions

OTHER

No Results Yet

NCT06375122 | RECRUITING

150 participants

Natural History Study of Kaposi Sarcoma

Study Type:: OBSERVATIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-05-15
Completion:: 2034-12-31

Conditions

Kaposi Sarcoma
HIV

No Results Yet

NCT06374797 | TERMINATED | PHASE2

122 participants

A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk"

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-07-01
Completion:: 2026-04-06

Conditions

Acute Kidney Injury

Interventions

DRUG

No Results Yet

NCT06362928 | WITHDRAWN | NA

0 participants

Safety and Effectiveness of the Akura Thrombectomy System in the Treatment of Acute Pulmonary Embolism

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2025-02-11
Completion:: 2026-06-17

Conditions

Pulmonary Embolism Acute

Interventions

DEVICE

No Results Yet

NCT06354751 | COMPLETED

40 participants

Maternity Care Experiences of Asylum-seeking and Refugee Women in Scotland

Study Type:: OBSERVATIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-05-01
Completion:: 2025-04-30

Conditions

Refugee
Asylum-seeking Women
Maternity

No Results Yet

NCT06350201 | ACTIVE_NOT_RECRUITING | NA

387 participants

Machine Learning-based Classification of Symptom Clusters and Online CBT

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2025-12-01
Completion:: 2026-04-17

Conditions

Depression and Anxiety Symptom

Interventions

BEHAVIORAL
OTHER

No Results Yet

NCT06345391 | COMPLETED

12 participants

Co-creation of Pain Science Education for Children Living Beyond Cancer

Study Type:: OBSERVATIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-04-16
Completion:: 2026-07-31

Conditions

Children Living Beyond Cancer (i.e. Child Cancer Survivor)

Interventions

OTHER

No Results Yet

NCT06342960 | TERMINATED | PHASE1/PHASE2

2 participants

KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2022-12-01
Completion:: 2025-12-22

Conditions

Lupus Nephritis
Lupus Nephritis - WHO Class III
Lupus Nephritis - WHO Class IV

Interventions

BIOLOGICAL
DRUG

No Results Yet

NCT06338267 | ACTIVE_NOT_RECRUITING

30 participants

Validating Innovative Biosensors for Rett Autonomic Symptom Tracking

Study Type:: OBSERVATIONAL
Last Updated:: 2026-08-31
Start Date:: 2025-03-03
Completion:: 2026-11-30

Conditions

Rett Syndrome

No Results Yet

NCT06336304 | TERMINATED

163 participants

NXT Post-Market Clinical Follow-up

Study Type:: OBSERVATIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-06-18
Completion:: 2026-06-30

Conditions

Urinary Incontinence
Urinary Obstruction
Urinary Bladder, Overactive
Urinary Bladder, Neurogenic
Urinary Incontinence, Urge

Interventions

DIAGNOSTIC_TEST

No Results Yet

NCT06332469 | COMPLETED | NA

30 participants

Evaluation of an Internet Based Education and Support Program for Patients Awaiting Kidney Transplantation

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-04-18
Completion:: 2025-05-31

Conditions

Chronic Kidney Diseases

Interventions

BEHAVIORAL

No Results Yet

NCT06319248 | RECRUITING | PHASE2

308 participants

MID-STEP (MIDodrine for Sepsis Treatment and Early vasoPressor Weaning) Trial

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-05-14
Completion:: 2029-05-30

Conditions

Sepsis
Low Blood Pressure

Interventions

DRUG
OTHER

No Results Yet

NCT06315075 | RECRUITING | NA

140 participants

Dialectical Behavior Therapy for Adolescents With Self-harm and Suicidal Behavior- an Open Trial

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-01-15
Completion:: 2027-12-31

Conditions

Self-harm
Suicidal Ideation
Suicide and Self-harm

Interventions

BEHAVIORAL

No Results Yet

NCT06313892 | COMPLETED | NA

26 participants

The Effect of Home-Based Tele-Exercise on Dialysis Patients

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-03-15
Completion:: 2024-06-12

Conditions

End Stage Renal Disease
Hemodialysis Complication

Interventions

BEHAVIORAL

No Results Yet

NCT06313398 | RECRUITING | EARLY_PHASE1

100 participants

Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-05-17
Completion:: 2029-05-01

Conditions

Sickle Cell Disease
Thalassemia
Hemoglobinopathy

Interventions

BIOLOGICAL

No Results Yet

NCT06306287 | COMPLETED | NA

132 participants

Adolescent Screening and Personalized Intervention Resource for Enhancement of Behavioral Health and Substance Use

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-02-15
Completion:: 2026-04-21

Conditions

Substance Use
Mental Health Issue

Interventions

BEHAVIORAL

No Results Yet

NCT06303765 | COMPLETED | NA

8 participants

Evaluating the Practice Resource for Driving After Stroke

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-02-01
Completion:: 2024-08-31

Conditions

Stroke, Acute
Driving
Occupational Therapy

Interventions

OTHER

No Results Yet

NCT06303193 | RECRUITING | PHASE1/PHASE2

160 participants

Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2026-09-03
Completion:: 2030-01-01

Conditions

Myelodysplastic Syndromes

Interventions

DRUG

No Results Yet

NCT06296641 | COMPLETED | NA

28 participants

Needs Navigation for Caregivers of AYAs

Study Type:: INTERVENTIONAL
Last Updated:: 2026-08-31
Start Date:: 2024-02-16
Completion:: 2026-06-28

Conditions

Cancer in Adolescence

Interventions

BEHAVIORAL

No Results Yet